Novel adjuvant compositions and vaccine formulations...

C - Chemistry – Metallurgy – 08 – B

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C08B 37/00 (2006.01) A61K 39/00 (2006.01) A61K 39/39 (2006.01)

Patent

CA 2219904

An adjuvant for administration to a host animal to enhance immune response, comprising a polysaccharide-phospholipid conjugate, whose polysaccharide moiety may for example comprise a modified glucan, chitosan, or alginate polysaccharide, conjugated to a phospholipid. The adjuvant may be suitably formulated with an antigen to provide a therapeutic vaccine for a variety of disease states and/or physiological conditions.

L'invention concerne un adjuvant destiné à être administré à un animal hôte pour renforcer la réponse immune, comprenant un conjugué de polysaccharide-phospholipide, dont la fraction polysaccharide peut, par exemple, comprendre une glucane, un chitosane ou un polysaccharide alginate modifié, conjugué avec un phospholipide. L'adjuvant peut avantageusement être formulé avec un antigène pour produire un vaccin thérapeutique destiné à une variété d'états pathologiques et/ou à une variété de conditions physiologiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel adjuvant compositions and vaccine formulations... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel adjuvant compositions and vaccine formulations..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel adjuvant compositions and vaccine formulations... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2020511

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.